The University of Hawai‘i Cancer Center (UHCancerCenter) joins Caris’ extensive network of leading cancer institutions and research consortia committed to improving patient outcomes through innovations in precision medicine. “UH Cancer Center’s focus on reducing the burden of cancer through research, education, patient care and community outreach makes them a valuable alliance member. We look forward to collaborating with their team of investigators on our shared mission of improving the outcomes of all patients affected by cancer,” said George W. Sledge, Jr., MD, EVP and Chief Medical Officer of Caris. Learn more: https://ow.ly/J7c550SZOuW
Caris Life Sciences’ Post
More Relevant Posts
-
In acknowledgment of World Ovarian Cancer Day on May 8th, we are highlighting a webinar with Dr. Kevin Holcomb, Dr. Ashley Gubbels, and Dr. Makunda Abdul-Mbacke. From a large academic medical center to a rural clinic, this webinar provides three different clinical viewpoints on how diagnostic tools can help triage adnexal masses and potentially impact the epithelial ovarian cancer patient journey. We encourage you to watch via: https://lnkd.in/gpTFayrG #OvarianCancer #HE4 #ROMA
-
-
In acknowledgment of World Ovarian Cancer Day on May 8th, we are highlighting a webinar with Dr. Kevin Holcomb, Dr. Ashley Gubbels, and Dr. Makunda Abdul-Mbacke. From a large academic medical center to a rural clinic, this webinar provides three different clinical viewpoints on how diagnostic tools can help triage adnexal masses and potentially impact the epithelial ovarian cancer patient journey. We encourage you to watch via: https://lnkd.in/gpTFayrG #OvarianCancer #HE4 #ROMA
-
-
In acknowledgment of World Ovarian Cancer Day on May 8th, we are highlighting a webinar with Dr. Kevin Holcomb, Dr. Ashley Gubbels, and Dr. Makunda Abdul-Mbacke. From a large academic medical center to a rural clinic, this webinar provides three different clinical viewpoints on how diagnostic tools can help triage adnexal masses and potentially impact the epithelial ovarian cancer patient journey. We encourage you to watch via: https://lnkd.in/gpTFayrG #OvarianCancer #HE4 #ROMA
-
-
In acknowledgment of World Ovarian Cancer Day on May 8th, we are highlighting a webinar with Dr. Kevin Holcomb, Dr. Ashley Gubbels, and Dr. Makunda Abdul-Mbacke. From a large academic medical center to a rural clinic, this webinar provides three different clinical viewpoints on how diagnostic tools can help triage adnexal masses and potentially impact the epithelial ovarian cancer patient journey. We encourage you to watch via: https://lnkd.in/gpTFayrG #OvarianCancer #HE4 #ROMA
In acknowledgment of World Ovarian Cancer Day on May 8th, we are highlighting a webinar with Dr. Kevin Holcomb, Dr. Ashley Gubbels, and Dr. Makunda Abdul-Mbacke. From a large academic medical center to a rural clinic, this webinar provides three different clinical viewpoints on how diagnostic tools can help triage adnexal masses and potentially impact the epithelial ovarian cancer patient journey. We encourage you to watch via: https://lnkd.in/gpTFayrG #OvarianCancer #HE4 #ROMA
-
-
Achieving equity in lung cancer screening is an imperative. Work led by Shanada Monestime, PharmD, BCOP and #GO2forLungCancer provides insight on an approach to attain equity in lung cancer screening. #LCSM #LungCancer #HOPA2024
GO2’s Director, Community Engaged Research Shanada Monestime, PharmD, BCOP, presented at the Hematology/Oncology Pharmacy Association (HOPA)'s annual meeting this week. She shared her study, “Unlocking Geographic Disparities in Lung Cancer Incidence Calls for Tailored Interventions and Pharmacist Partnerships,” that identifies counties with significant disparities in lung cancer. The study found that it is critical to establish partnerships with pharmacists in communities such as Washington, D.C., North Carolina, and Virginia to customize screening interventions to increase lung cancer screening rates: https://bit.ly/3J9wljN #LCSM #LungCancer #HOPA2024
-
-
As we commemorate World Cancer Day, let us acknowledge the tireless efforts of researchers and healthcare professionals and the resilience of cancer survivors. Their collective commitment to clinical research is instrumental in shaping a future where cancer is not only treatable but ultimately conquered. Read the full article using the link below. #bispharmclinical #clinicaltrials #WorldCamcerDay
-
GO2 and our partners are committed to advancing #LungCancerResearch—but we can’t do it without hearing from those directly impacted. If you’re a #LungCancerPatient or #caregiver, your voice is critical in helping us identify the most pressing research priorities. Please take a moment to complete this brief survey by Oct. 15 and make a difference in the future of lung cancer research. Share your insights here: https://lnkd.in/ea4vzXse #PatientVoices #CaregiverSupport
GO2 Global Knowledge Center for Lung Cancer
gkc.go2.org
-
New episode of #CancerRegistryWorld! Join Steven Friedman, MHSA, Senior Advisor and SEER Program Manager at the National Cancer Institute, as he highlights the pivotal role of the SEER Cancer Registry. For decades, SEER has collected extensive data from numerous sites across the U.S., fueling critical clinical research and improving outcomes for cancer patients. Curious about how this data is shaping the future of cancer research and patient care? Tune in now to learn more! https://lnkd.in/gmWKSGZt
-
-
Listen to a captivating conversation between Dr. Emil Lou, Associate Professor of Medicine at Masonic Cancer Center, University of Minnesota, and Dr. Chadi Nabhan, Chairman of Caris Precision Oncology Alliance™, about the intricate connections between pathogens and cancer. Tune in, gain valuable insights into the current landscape, and discover what the future holds for this dynamic intersection of science and medicine. https://ow.ly/OPqG50QtJvE
-
Our recently-published Impact Report showcases the broad-ranging impacts made by OICR-affiliated scientists, clinicians and patient partners over the past year – what they mean for now and what they mean for the future. It shows how our collective efforts, as Ontario’s cancer research institute, are delivering on our commitment to improve the lives of people today, as well as future generations. https://lnkd.in/eVD3QP4
OICR Impact report 2023/24 - Now > Next
reports.oicr.on.ca
